Literature DB >> 26437953

Prognostic factors and genes associated with endometrial cancer based on gene expression profiling by bioinformatics analysis.

Ying Zhang1,2, Wei Zhang1,2, Xinglan Li1,2, Dapeng Li1, Xiaoling Zhang1, Yajie Yin1,2, Xiangyun Deng1,2, Xiugui Sheng3.   

Abstract

BACKGROUND: Endometrial cancer (EC) is the most prevalent malignancy worldwide. Although several efforts had been made to explore the molecular mechanism responsible for EC progression, it is still not fully understood. AIM OF THE STUDY: To evaluate the clinical characteristics and prognostic factors of patients with EC, and further to search for novel genes associated with EC progression.
METHODS: We recruited 328 patients with EC and analyzed prognostic factors using Cox proportional hazard regression model. Further, a gene expression profile of EC was used to identify the differentially expressed genes (DEGs) between normal samples and tumor samples. Subsequently, Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis ( http://www.genome.jp/kegg/ ) for DEGs were performed, and then protein-protein interaction (PPI) network of DEGs as well as the subnetwork of PPI were constructed with plug-in, MCODE by mapping DEGs into the Search Tool for the Retrieval of Interacting Genes database.
RESULTS: Our results showed that body mass index (BMI), hypertension, myometrial invasion, pathological type, and Glut4 positive expression were prognostic factors in EC (P < 0.05). Bioinformatics analysis showed that upregulated DEGs were associated with cell cycle, and downregulated DEGs were related to MAPK pathway. Meanwhile, PPI network analysis revealed that upregulated CDK1 and CCNA2 as well as downregulated JUN and FOS were listed in top two nodes with high degrees.
CONCLUSIONS: Patients with EC should be given more focused attentions in respect of pathological type, BMI, hypertension, and Glut4-positive expression. In addition, CDK1, CCNA2, JUN, and FOS might play important roles in EC development.

Entities:  

Keywords:  Endometrial cancer; Gene expression profile; Molecular mechanism; Prognostic factors

Mesh:

Substances:

Year:  2015        PMID: 26437953     DOI: 10.1007/s00404-015-3886-8

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  5 in total

1.  Investigating the Role of Telomere and Telomerase Associated Genes and Proteins in Endometrial Cancer.

Authors:  Alice Bradfield; Lucy Button; Josephine Drury; Daniel C Green; Christopher J Hill; Dharani K Hapangama
Journal:  Methods Protoc       Date:  2020-09-03

2.  The HOXC-AS2/miR-876-5p/HKDC1 axis regulates endometrial cancer progression in a high glucose-related tumor microenvironment.

Authors:  Jing Guo; Feng Ye; Wenli Xie; Xinxin Zhang; Ru Zeng; Wang Sheng; Yanjun Mi; Xiugui Sheng
Journal:  Cancer Sci       Date:  2022-05-29       Impact factor: 6.518

3.  Identification of Potential Crucial Genes Associated With the Pathogenesis and Prognosis of Endometrial Cancer.

Authors:  Li Liu; Jiajing Lin; Hongying He
Journal:  Front Genet       Date:  2019-04-26       Impact factor: 4.599

4.  Identification of prognosis markers for endometrial cancer by integrated analysis of DNA methylation and RNA-Seq data.

Authors:  Xiao Huo; Hengzi Sun; Dongyan Cao; Jiaxin Yang; Peng Peng; Mei Yu; Keng Shen
Journal:  Sci Rep       Date:  2019-07-09       Impact factor: 4.379

5.  Identification of core genes in the progression of endometrial cancer and cancer cell-derived exosomes by an integrative analysis.

Authors:  Shuang Shi; Qiang Tan; Fuqiang Feng; Heping Huang; Jingjie Liang; Dingren Cao; Zhengguang Wang
Journal:  Sci Rep       Date:  2020-06-17       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.